A look at new uses for obesity drugs, and new treatments for schizophrenia and muscular dystrophy

December 30, 2024 Check out STAT+

Sponsored By

Adobe The biggest medical advances of 2024 STAT's Matthew Herper looks at the biggest medical advances of 2024 — new uses for obesity drugs, new treatments for schizophrenia, muscular dystrophy. By Matthew Herper Fixing pulse oximeters requires federal might and possible legal action, researchers say The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may be needed to spur improvement. By Usha Lee McFarling, Lizzy Lawrence, and Anil Oza STAT+ | GOP works to square making America healthy with taking away health insurance Does health insurance make people healthier? RFK Jr. 's Make America Healthy Again movement touts other paths to well-being. By John Wilkerson The Carter Center How Jimmy Carter's global health efforts elevated 'the art of the possible' The causes the former president espoused are diseases whose names we barely know and that mainly afflict the poor and powerless By Helen Branswell Aletha Maybank to step down as AMA's chief health equity officer Aletha Maybank, who became the American Medical Association's first chief health equity officer five and half years ago, is leaving the organization.  By Usha Lee McFarling 3 addiction and drug policy issues to watch in 2025  STAT's '3 to Watch' series looks at addiction policy: Future of supervised consumption, use of addiction medications, buprenorphine access via telehealth. By Lev Facher Adobe STAT+ | Axsome to send Alzheimer's disease drug to FDA, despite mixed Phase 3 results The therapy is a combination of dextromethorphan, commonly found in cough suppressants, and a generic form of the depression treatment Wellbutrin. By Allison DeAngelis Opinion: Extending Medicare coverage to obesity medications is imperative With legislative momentum, there is growing recognition that extending Medicare coverage to obesity medications is imperative. By Anand Parekh, William Dietz, and Joseph Nadglowski

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser